Acdal, Teofilo R.

HRN: 24-23-80  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/10/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/10/2023
12/16/2023
IVT
1.5g
Q6
CAP MR
Waiting Final Action 
12/14/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/14/2023
12/20/2023
IV
4.5gm
Q8
Cap Mr
Waiting Final Action 
12/15/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/15/2023
12/21/2023
IV
2.25gm
Q6
Septicemia Renal Adjustment
Waiting Final Action 
12/18/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/18/2023
01/08/2024
IV
4.5gms
Q6
Sepsis
Waiting Final Action 
12/29/2023
CEFTAZIDIME 1GM (VIAL)
12/29/2023
01/04/2024
IV
1g
Q8
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: